1. Home
  2. MTC vs TIL Comparison

MTC vs TIL Comparison

Compare MTC & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTC

MMTec Inc.

HOLD

Current Price

$6.96

Market Cap

71.8M

Sector

Technology

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.90

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTC
TIL
Founded
2015
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.8M
74.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
MTC
TIL
Price
$6.96
$7.90
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
37.0K
21.0K
Earning Date
12-13-2024
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$5.67
52 Week High
$7.00
$42.75

Technical Indicators

Market Signals
Indicator
MTC
TIL
Relative Strength Index (RSI) 66.70 45.29
Support Level $0.74 $8.07
Resistance Level $7.00 $9.05
Average True Range (ATR) 0.77 0.46
MACD -0.00 -0.01
Stochastic Oscillator 97.62 48.60

Price Performance

Historical Comparison
MTC
TIL

About MTC MMTec Inc.

MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: